Social Egg Freezing: Will Health Professionals Offer it ?

NCT ID: NCT06529224

Last Updated: 2024-07-31

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

2500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-04-01

Study Completion Date

2025-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In 2021, the revision of bioethics laws opened the door to elective egg freezing. This gives women, between their 29th and 37th birthdays, the opportunity to freeze their eggs in order to combat age decline fertility. However, communication about this new possibility has remained limited both toward women and their health professional.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Thus, the hypothesize of this study is that these professionals, namely physicians, gynecologists and midwives, are insufficiently aware of age-related fertility decline and unaware of the possibility of elective egg freezing.

This multicenter observational cross-sectional study whose objective will be:

* To assess the knowledge of these professionals in terms of age-related fertility decline.
* To measure their propensity to spontaneously broach the subject with their childless patients.
* To assess their knowledge and support for elective egg freezing. This study will be done using an online questionnaire that will be distributed in electronic format to all the health professionals concerned in the participating areas.

This study will provide valuable knowledge on the perception of elective egg freezing by health professionals, determine their training needs and motivate new information campaigns on this subject.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Infertility,Female

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Health professionals

General practitioner, gynecologist or midwife

Online questionnaire

Intervention Type OTHER

An online questionnaire will be distributed in electronic format to all the healthcare professionals concerned.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Online questionnaire

An online questionnaire will be distributed in electronic format to all the healthcare professionals concerned.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Be a general practitioner, gynecologist or midwife in practice for at least one year
* Follow patients between 29 and 37 years old (for their contraception for example)

Exclusion Criteria

* Have been practising for less than a year
* Have no patients aged between 29 and 37
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier Universitaire de Saint Etienne

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jean-Philippe KLEIN, MD

Role: PRINCIPAL_INVESTIGATOR

CHU SAINT-ETIENNE

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU Saint Etienne

Saint-Etienne, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jean-Philippe KLEIN, MD

Role: CONTACT

(0)477828997 ext. +33

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IRBN942023/CHUSTE

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Egg Freezing Pilot Study
NCT00839839 COMPLETED NA
Egg Quality Assessment
NCT06609421 SUSPENDED
Oocyte Cryopreservation
NCT01232972 TERMINATED NA